Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis

Aspirin therapy has shown protective effects against hepatocellular carcinoma (HCC) in preclinical studies. However, it is unclear whether aspirin therapy lowers the risk of HCC in patients with alcoholic cirrhosis. A retrospective analysis of data from 949 consecutive patients with alcoholic cirrho...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Shin, Sangdeok, Lee, Sang Hoon, Lee, Minjong, Kim, Ji Hyun, Lee, Wongu, Lee, Hyun Woo, Park, Min Soo, Park, Seungwoo, Kim, Tae Suk, Choi, Dae Hee
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2020
Matèries:
4500
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7478404/
https://ncbi.nlm.nih.gov/pubmed/32118712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000019008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars